AKYA: Akoya Biosciences, Inc. Stock

by  •  • Comments Off on AKYA: Akoya Biosciences, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 49.87
Enterprise Value ($M) 182.18
Book Value ($M) -5.89
Book Value / Share -0.12
Price / Book -8.47
NCAV ($M) -52.33
NCAV / Share -1.05
Price / NCAV -0.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.31
Return on Equity (ROE) -1.45

Liquidity (mrq)
Quick Ratio 0.40
Current Ratio 0.61

Balance Sheet (mrq) ($M)
Current Assets 66.21
Assets 112.65
Liabilities 118.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 81.67
Operating Income -41.18
Net Income -55.37

Cash Flow Statement (mra) ($M)
Cash From Operations -44.10
Cash from Investing -24.05
Cash from Financing -3.21

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-30 13D/A Quanterix Corp 55.60 10.27
11-04 13G/A Schindel Yair Chaim 9.86 58.54
08-28 13G Blue Water Life Science Advisors, LLC 9.56

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 28,109 95,645 29.39
2025-05-14 85,356 211,731 40.31
2025-05-13 126,995 406,076 31.27
2025-05-12 122,700 288,992 42.46

(click for more detail)

Similar Companies
BRKR – Bruker Corporation CGNX – Cognex Corporation


Financial data and stock pages provided by
Fintel.io